Literature DB >> 3947525

A comparative study of two doses of salbutamol nebulized at 4 and 8 litres per minute in patients with chronic asthma.

J G Douglas, M J Leslie, G K Crompton, I W Grant.   

Abstract

A comparative study of the clinical response to salbutamol nebulized by an Inspiron Mini-Neb using flow rates of 4 and 8 litres/min is described. Forty patients with chronic asthma were given doses of approximately 1 mg and 5 mg of salbutamol using flow rates of either 4 or 8 litres/min. The two flow rates and the two dosages produced similar increases in FEV1 and FVC and similar changes in pulse rate. These results demonstrate that flow rates of 4 litres/min, such as can be produced by a domestic oxygen cylinder, and doses of 1 mg salbutamol are effective in the treatment of patients with chronic reversible airflow obstruction. While we do not advocate the general use of oxygen cylinders to drive nebulizers, our study shows that this form of administration produces a bronchodilator response similar to that using a flow rate of 8 litres/min.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3947525     DOI: 10.1016/0007-0971(86)90010-0

Source DB:  PubMed          Journal:  Br J Dis Chest        ISSN: 0007-0971


  4 in total

Review 1.  In vitro and in vivo aspects of cascade impactor tests and inhaler performance: a review.

Authors:  Jolyon Mitchell; Steve Newman; Hak-Kim Chan
Journal:  AAPS PharmSciTech       Date:  2007-12-21       Impact factor: 3.246

2.  Inaccurate calculation of drug output from nebulisers.

Authors:  C O'Callaghan; A R Clarke; A D Milner
Journal:  Eur J Pediatr       Date:  1989-02       Impact factor: 3.183

3.  Effect of nebulised aerosol size on lung deposition in patients with mild asthma.

Authors:  M M Clay; S W Clarke
Journal:  Thorax       Date:  1987-03       Impact factor: 9.139

4.  Effect of particle size of bronchodilator aerosols on lung distribution and pulmonary function in patients with chronic asthma.

Authors:  D M Mitchell; M A Solomon; S E Tolfree; M Short; S G Spiro
Journal:  Thorax       Date:  1987-06       Impact factor: 9.139

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.